Patient Guide: A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 16 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06577025
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple Myeloma
Phase: PHASE2

Find a Study Location Near You

This study is available at 16 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • San Francisco, California
  • Iowa City, Iowa
  • • And 13 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily